Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The venous vasculature, or venous system, is the network of veins that return deoxygenated blood from tissues to the heart. Veins have thinner walls, less smooth muscle, and larger lumens than arteries, allowing them to act as blood reservoirs and capacitance vessels. They are crucial for maintaining circulatory dynamics and are implicated in various vascular diseases, but the term "venous vasculature" is anatomical, not a single molecular entity or drug target.
Sclerosing agent: induces endothelial damage, causing fibrosis and vein occlusion; mTOR inhibitor: reduces abnormal vessel proliferation in malformations
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Venous vasculature.